These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16890705)

  • 1. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
    Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
    J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of patients with familial versus sporadic prostate cancer.
    Roehl KA; Loeb S; Antenor JA; Corbin N; Catalona WJ
    J Urol; 2006 Dec; 176(6 Pt 1):2438-42; discussion 2442. PubMed ID: 17085123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.
    Rouprêt M; Fromont G; Bitker MO; Gattegno B; Vallancien G; Cussenot O
    Urology; 2006 May; 67(5):1028-32. PubMed ID: 16698363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
    Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
    J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.
    Roehl KA; Han M; Ramos CG; Antenor JA; Catalona WJ
    J Urol; 2004 Sep; 172(3):910-4. PubMed ID: 15310996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
    Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antegrade radical retropubic prostatectomy with preliminary ligation of vascular pedicles in 614 consecutive patients.
    Kawakami S; Fukui I; Yonese J; Okubo Y; Yamamoto S; Tsukamoto T; Ishikawa Y
    Jpn J Clin Oncol; 2007 Jul; 37(7):528-33. PubMed ID: 17720739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.
    Porter CR; Kodama K; Gibbons RP; Correa R; Chun FK; Perrotte P; Karakiewicz PI
    J Urol; 2006 Aug; 176(2):569-74. PubMed ID: 16813891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance.
    Sengupta S; Christensen CM; Zincke H; Slezak JM; Leibovich BC; Bergstralh EJ; Myers RP; Blute ML
    J Urol; 2006 Aug; 176(2):559-63. PubMed ID: 16813889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
    Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML
    Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
    BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2001 Aug; 166(2):416-9. PubMed ID: 11458039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial and hereditary prostate cancer by definition in an italian surgical series: clinical features and outcome.
    Sacco E; Prayer-Galetti T; Pinto F; Ciaccia M; Fracalanza S; Betto G; Pagano F
    Eur Urol; 2005 Jun; 47(6):761-8. PubMed ID: 15925070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival.
    Nguyen CT; Reuther AM; Stephenson AJ; Klein EA; Jones JS
    J Urol; 2009 Jan; 181(1):75-80. PubMed ID: 19012927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy.
    Lee KL; Marotte JB; Ferrari MK; McNeal JE; Brooks JD; Presti JC
    Urology; 2005 Feb; 65(2):311-5. PubMed ID: 15708044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.
    Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Partin AW
    J Urol; 2006 Oct; 176(4 Pt 1):1404-8. PubMed ID: 16952644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: a single institutional study.
    Hachiya T; Okada Y; Kawata N; Hirano D; Yoshida T; Okada K; Takimoto Y
    Int J Urol; 2004 Oct; 11(10):862-9. PubMed ID: 15479291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era.
    Gjertson CK; Asher KP; Sclar JD; Goluboff ET; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Oct; 70(4):723-7. PubMed ID: 17991544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.